CSF biomarkers and clinical progression of Parkinson disease.

Sara Hall; Yulia Surova; Annika Ohrfelt; Henrik Zetterberg; Daniel Lindqvist; Oskar Hansson

doi:10.1212/WNL.0000000000001098

CSF biomarkers and clinical progression of Parkinson disease.

Sara Hall, Yulia Surova, Annika Ohrfelt, Henrik Zetterberg, Daniel Lindqvist, Oskar Hansson

Research output: Contribution to journal › Article › peer-review

Abstract

To investigate whether certain CSF biomarkers at baseline can predict future progression of motor symptoms and cognitive decline in patients with Parkinson disease (PD).

Original language	English
Pages (from-to)	57-63
Journal	Neurology
Volume	84
Issue number	1
DOIs	https://doi.org/10.1212/WNL.0000000000001098
Publication status	Published - 2015

Subject classification (UKÄ)

Neurology

Access to Document

10.1212/WNL.0000000000001098

1 Doctoral Thesis (compilation)

Biomarkers in Parkinson's disease and related disorders. Diagnostic value of biochemical markers and their relation to disease progression
Hall, S., 2017, Lund: Lund University: Faculty of Medicine. 91 p.
Research output: Thesis › Doctoral Thesis (compilation)

File

Cite this

@article{9b9cf6b6cae14c88905acb4b57bf51c7,

title = "CSF biomarkers and clinical progression of Parkinson disease.",

abstract = "To investigate whether certain CSF biomarkers at baseline can predict future progression of motor symptoms and cognitive decline in patients with Parkinson disease (PD).",

author = "Sara Hall and Yulia Surova and Annika Ohrfelt and Henrik Zetterberg and Daniel Lindqvist and Oskar Hansson",

year = "2015",

doi = "10.1212/WNL.0000000000001098",

language = "English",

volume = "84",

pages = "57--63",

journal = "Neurology",

issn = "1526-632X",

publisher = "Lippincott Williams & Wilkins",

number = "1",

}

TY - JOUR

T1 - CSF biomarkers and clinical progression of Parkinson disease.

AU - Hall, Sara

AU - Surova, Yulia

AU - Ohrfelt, Annika

AU - Zetterberg, Henrik

AU - Lindqvist, Daniel

AU - Hansson, Oskar

PY - 2015

Y1 - 2015

N2 - To investigate whether certain CSF biomarkers at baseline can predict future progression of motor symptoms and cognitive decline in patients with Parkinson disease (PD).

AB - To investigate whether certain CSF biomarkers at baseline can predict future progression of motor symptoms and cognitive decline in patients with Parkinson disease (PD).

U2 - 10.1212/WNL.0000000000001098

DO - 10.1212/WNL.0000000000001098

M3 - Article

C2 - 25411441

SN - 1526-632X

VL - 84

SP - 57

EP - 63

JO - Neurology

JF - Neurology

IS - 1

ER -

CSF biomarkers and clinical progression of Parkinson disease.

Abstract

Subject classification (UKÄ)

Access to Document

Research output

Biomarkers in Parkinson's disease and related disorders. Diagnostic value of biochemical markers and their relation to disease progression

Cite this